Back

Robotic-assisted local epicardial radiofrequency ablation vs. catheter ablation first in patients with persistent and long-standing persistent atrial fibrillation: a multicenter retrospective study.

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Surgical aspects in atrial fibrillation management Rhythm Control, Hybrid Therapy EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Stefano Schena

Medical College of Wisconsin, Milwaukee (United States of America)

5 More presentations in this session

Presentation thumbnail
Endo-epicardial strategy in persistent and long standing persistent AF: comparing AF binary-Burden outcomes and clinical implications
Doctor S. Branzoli (Jette, BE)
Abstract Slides Video
Presentation thumbnail
Feasibility, safety and efficacy of a novel simplified approach for epicardial ligation
Doctor K. Nentwich (Bad Neustadt an der Saale, DE)
Abstract Slides Video
Presentation thumbnail
Catheter ablation for recurrent atrial arrhythmias after surgical atrial fibrillation ablation: procedural characteristics, safety, and clinical outcomes
Doctor J. Schipper (Cologne, DE)
Abstract Slides Video
Presentation thumbnail
Hybrid vs. endocardial catheter ablation for persistent and longstanding atrial fibrillation: a systematic review and meta-analysis
Associate Professor A. Menezes Junior (Goiania, BR)
Abstract Slides Video
Presentation thumbnail
The value of standalone thoracoscopic epicardial left appendage exclusion and isolation in a multidisciplinary practice: long term clinical outcomes and quality of life
Doctor S. Branzoli (Jette, BE)
Abstract Slides Video

Access the full session

Session thumbnail
Surgical aspects in atrial fibrillation management

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Session
Late-Breaking Science: persistent atrial fibrillation ablation
thumbnail
Congress Session
Late-Breaking Science: paroxysmal atrial fibrillation ablation
thumbnail
Congress Session
Targeting advanced atrial fibrillation: the Hybrid AF Therapies advantage

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources